Formation and activity of NLRP3 inflammasome and histopathological changes in the lung of corpses with COVID-19

被引:0
|
作者
Morteza Gholaminejhad
Mehdi Forouzesh
Babak Ebrahimi
Seyed Amirhosein Mahdavi
Seyed Davood Mirtorabi
Amirreza Liaghat
Seyed Jalil Monabati
Muhammad Obaid Hamza
Gholamreza Hassanzadeh
机构
[1] Legal Medicine Organization,Legal Medicine Research Center
[2] Tehran University of Medical Sciences,Department of Anatomy, School of Medicine
[3] Legal Medicine Research Center,Department of Medical Laboratory Techniques, College of Medical Technical
[4] Legal Medicine Organization,Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine
[5] Al-Farahidi University,undefined
[6] Tehran University of Medical Sciences,undefined
来源
关键词
COVID-19; NLRP3; Inflammasome; Lung; Histopathology; Coronavirus;
D O I
暂无
中图分类号
学科分类号
摘要
COVID-19 is a contagious disease that attacks many organs but the lungs are the main organs affected. The inflammasome activation results in the exacerbation of inflammatory response in infectious disease. The aim of this study is to investigate the formation and activity of the NLRP3 inflammasome complex and the histopathological changes caused by the coronavirus in the lung of deceased persons with COVID-19. In total, 10 corpses; 5 corpses with no history of any infectious diseases and COVID-19 and 5 corpses with the cause of death of COVID-19 were included in this study. Lung tissue samples were harvested during autopsy under safe conditions. Fresh tissues in each group were used to measure the genes expression and proteins level of NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α and a routine hematoxylin and eosin staining was performed for histological assessment. Data are represented as the means ± SD. Statistical significance difference was accepted at a p-value less than 5%. The NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α genes expression and proteins level were elevated in the lung of the COVID-19 group in comparison with the control group. Histological findings presented the increasing number of polymorphonuclear leukocytes, macrophages and also pulmonary fibrosis in the lungs of corpses with the cause of death of COVID-19. High expression of NLRP3 inflammasome components and its relation with the pathophysiology of the coronavirus-infected lung suggested that targeting the NLRP3 inflammasome could be helpful in achieving a more effective treatment in patients with COVID-19.
引用
收藏
页码:883 / 890
页数:7
相关论文
共 50 条
  • [31] Probiotics Regulating Inflammation via NLRP3 Inflammasome Modulation: A Potential Therapeutic Approach for COVID-19
    Kasti, Arezina N.
    Synodinou, Kalliopi D.
    Pyrousis, Ioannis A.
    Nikolaki, Maroulla D.
    Triantafyllou, Konstantinos D.
    MICROORGANISMS, 2021, 9 (11)
  • [32] Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients
    Zhang, Hongliang
    Tang, Yujie
    Tao, Jinhui
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [33] Genetic Activation of Nlrp3 Reveals NLRP3 Inflammasome Role in Osteoclast Activity
    Qu, Chao
    Abu-Amer, Samer
    Bonar, Sheri
    Kading, Jacqueline
    Abu-Amer, Yousef
    Civitelli, Roberto
    Mbalaviele, Gabriel
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S88 - S88
  • [34] The role of the microbiome and the NLRP3 inflammasome in the gut and lung
    Donovan, Chantal
    Liu, Gang
    Shen, Sj
    Marshall, Jacqueline E.
    Kim, Richard Y.
    Alamao, Charlotte A.
    Budden, Kurtis F.
    Choi, Jaesung P.
    Kohonen-Corish, Maija
    El-Omar, Emad M.
    Yang, Ian A.
    Hansbro, Philip M.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 108 (03) : 925 - 935
  • [35] A novel role for the NLRP3 inflammasome in lung cancer
    Petrilli, Virginie
    Bodnar, Melanie
    Guey, Baptiste
    Hacot, Sabine
    Lantuejoul, Sylvie
    CANCER RESEARCH, 2015, 75
  • [36] NLRP3 Inflammasome: A key contributor to the inflammation formation
    Zhang, Wen-Juan
    Li, Ke-Yun
    Lan, Yi
    Zeng, Han-Yi
    Chen, Shui-Qin
    Wang, Hui
    FOOD AND CHEMICAL TOXICOLOGY, 2023, 174
  • [37] NLRP3 Inflammasome associated proteins are predictive of COVID19 patient hospitalisation
    Donnelly, Shauna
    Bond, Raymond
    Peace, Aaron
    Rai, Taranjit Singh
    Lynch, Seodhna
    McDaid, Darren
    McLaughlin, Joesph
    English, Andrew
    Walsh, Colum
    Shulka, Priyank
    Murray, Elaine
    Zhang, Shu-Dong
    Chemaly, Melody
    O'Kane, Maurice
    Kelly, Martin
    Bhavsar, Manav
    Gibson, David
    Bjourson, Tony
    McGilligan, Victoria
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 790 - 791
  • [38] Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice
    Zeng, Jianxiong
    Xie, Xiaochun
    Feng, Xiao-Li
    Xu, Ling
    Han, Jian-Bao
    Yu, Dandan
    Zou, Qing-Cui
    Liu, Qianjin
    Li, Xiaohong
    Ma, Guanqin
    Li, Ming-Hua
    Yao, Yong-Gang
    EBIOMEDICINE, 2022, 75
  • [39] Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19
    Shah, Adnan
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [40] Pulmonary vascular inflammation with fatal coronavirus disease 2019 (COVID-19): possible role for the NLRP3 inflammasome
    Oindrila Paul
    Jian Qin Tao
    Eric West
    Leslie Litzky
    Michael Feldman
    Kathleen Montone
    Chamith Rajapakse
    Christian Bermudez
    Shampa Chatterjee
    Respiratory Research, 23